Table 2.
Clinical characteristics of the TCGA PRAD cohort and the preselected subcohort
| TCGA PRAD | TCGA PRAD subcohort | ||
|---|---|---|---|
| Full cohort | Good prognosisa | Poor prognosisa | |
| n | 477 | 27 | 57 |
| Age (mean ± sd) | 61.06 ± 6.9 | 57.23 ± 6.7 | 62.46 ± 6 |
| Stage (path. T) | |||
| n.a. | 6 | 0 | 0 |
| pT2a | 13 | 1 | 0 |
| pT2b | 6 | 3 | 0 |
| pT2c | 161 | 23 | 0 |
| pT3a | 153 | 0 | 24 |
| pT3b | 129 | 0 | 31 |
| pT4 | 9 | 0 | 2 |
| Gleason score | |||
| 6 | 43 | 6 | 0 |
| 7 | 243 | 17 | 12 |
| 8 | 61 | 2 | 8 |
| 9 | 127 | 2 | 36 |
| 10 | 3 | 0 | 1 |
n.a. not available
aGood prognosis defined as lack of BCR for at least 5 years and stage < pT3. Poor prognosis defined as BCR within 3 years and stage ≥ pT3